Post-approval studies (Phase 4)WithdrawnNCT02101164
What this trial is testing
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
Who this might be right for
Solid TumorMetastatic Bone Disease
Amgen